Hereditary hemochromatosis is autosomal recessive in its most common form. This means you need to inherit a faulty copy of the HFE gene from both parents to be at risk for iron overload. Carrying just one copy makes you a carrier but typically does not cause disease. There is one notable exception: a rarer type called ferroportin disease (type 4) follows an autosomal dominant pattern, meaning a single copy of the mutation can cause problems.
How the Most Common Type Is Inherited
About 90% of hereditary hemochromatosis cases involve mutations in the HFE gene, located on chromosome 6. This form, sometimes called type 1 or HFE-related hemochromatosis, requires two defective copies of the gene. If you inherit only one, your body’s iron regulation stays mostly intact. You’re a carrier, and you’ll likely never know it without genetic testing.
The most clinically significant mutation is called C282Y. People who are homozygous for C282Y (meaning they inherited that specific variant from both parents) have the highest risk of developing iron overload. The C282Y mutation disrupts a key protein that helps regulate how much iron your body absorbs from food. Without it functioning properly on both copies, the body lacks an effective brake on iron absorption, and iron slowly accumulates in the liver, heart, joints, and other organs over decades.
A second common variant, H63D, also exists. People who carry one C282Y and one H63D (called compound heterozygotes) have slightly higher iron markers than the general population, but their risk of actual iron overload disease is very low. In one large study, only 1 of 82 male compound heterozygotes and 0 of 95 females developed documented iron overload-related disease, compared to 28% of male C282Y homozygotes by age 65.
Not Everyone With Two Mutations Gets Sick
One of the most important things to understand about hemochromatosis genetics is that having two copies of C282Y does not guarantee you’ll develop symptoms. Geneticists describe hemochromatosis as having “low clinical penetrance,” which simply means the gene doesn’t always produce disease even when both copies are present.
Roughly 1 in 10 male C282Y homozygotes will develop severe liver disease during their lifetime if the iron buildup goes undetected and untreated. Women are at lower risk, partly because menstruation and pregnancy naturally reduce iron stores for much of their lives. In screening studies, liver problems were about twice as common in homozygotes as in people without the mutations, but the majority of homozygotes still never developed serious complications. This is why some people discover they’re homozygous through routine bloodwork or family screening and feel perfectly fine.
How Common Are These Mutations?
HFE mutations are most prevalent in people of Northern European descent. Between 5% and 10% of Northern Europeans carry at least one copy of C282Y, and roughly 1 in 100 to 1 in 400 people in these populations are homozygous. That makes hereditary hemochromatosis one of the most common single-gene disorders in people of European ancestry, even though most carriers never realize they have it.
The condition is much rarer in African, Asian, and Hispanic populations, where the C282Y variant is uncommon.
Rarer Types and Their Inheritance
While HFE-related hemochromatosis gets the most attention, several other genetic forms exist, and nearly all follow the same recessive pattern.
- Types 2A and 2B (juvenile hemochromatosis): Caused by mutations in the HJV or HAMP genes, these are also autosomal recessive. They tend to be far more aggressive, with iron overload appearing in the teens or twenties rather than middle age. Heart failure and hormonal problems are common early features. Each sibling of an affected person has a 25% chance of also being affected if both parents are carriers.
- Type 3: Caused by mutations in the TFR2 gene, also autosomal recessive, with a clinical picture similar to HFE hemochromatosis.
- Type 4 (ferroportin disease): This is the exception. It follows an autosomal dominant inheritance pattern, meaning a single mutated copy of the SLC40A1 gene is enough to cause disease. It’s the second most common form of primary iron overload after HFE-related hemochromatosis, though it’s still relatively rare. Ferroportin disease looks different on lab tests: iron tends to accumulate in different cell types, and ferritin levels can be very high even when transferrin saturation is normal or low.
What Recessive Inheritance Means for Families
If you’ve been diagnosed with HFE-related hemochromatosis, both of your parents are at minimum carriers. Each of your siblings had a 25% chance at conception of inheriting both mutations, a 50% chance of being a carrier, and a 25% chance of inheriting neither. Your children will definitely inherit one of your mutated copies, but whether they’re at risk for disease depends on whether your partner also carries an HFE mutation.
Current guidelines recommend that first- and second-degree relatives of anyone diagnosed with hereditary hemochromatosis be offered screening, which includes both blood iron studies and genetic testing. If you’re planning to have children, your partner can be tested too. Given how common the carrier state is among Northern Europeans, the chance that a random partner carries at least one HFE variant is not trivial.
Screening and Early Detection
The initial screening for hemochromatosis involves two blood tests: transferrin saturation and serum ferritin. Transferrin saturation above 45%, or ferritin above 200 mcg/L in women or 300 mcg/L in men, warrants further investigation with genetic testing for C282Y and H63D mutations.
Early detection matters precisely because the disease is so treatable when caught before organ damage occurs. The treatment is straightforward: regular blood removal (similar to blood donation) to bring iron levels down. People diagnosed early and treated consistently have a normal life expectancy. The challenge is that symptoms like fatigue, joint pain, and skin darkening develop gradually and overlap with dozens of other conditions, so many cases aren’t caught until significant iron has already accumulated. Knowing your family’s genetic status is the most reliable shortcut to early diagnosis.